<DOC>
	<DOCNO>NCT01576198</DOCNO>
	<brief_summary>RATIONALE : Studying sample blood , tissue , bone marrow patient cancer laboratory may help doctor learn change occur DNA identify biomarkers related cancer . PURPOSE : This research trial study biomarkers sample young patient Wilms tumor .</brief_summary>
	<brief_title>Studying Biomarkers Samples From Younger Patients With Wilms Tumor</brief_title>
	<detailed_description>OBJECTIVES : - To analyze 250 favorable-histology Wilms tumor ( FHWT ) sample patient register NWTS4 gain 1q 15q , loss 1p , 16q , 17p , 22q subtelomeric multiplex ligation-dependent probe amplification ( MLPA ) , determine association relapse-free overall survival . - To develop robust multiplex MLPA test use multiple synthesize probe target identify significantly associate relapse Aim 1 . - To validate multiplex MLPA test design test Aim 2 independent set 1727 FHWT 250 anaplastic WT register NWTS-5 . OUTLINE : Archived DNA sample analyze gain 1q 15q , loss 1p , 16q , 17p , 22q MLPA . Assay result research accuracy , clinical validity , sensitivity , precision , potential analytical interference .</detailed_description>
	<mesh_term>Kidney Neoplasms</mesh_term>
	<mesh_term>Wilms Tumor</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : DNA sample FHWT patient register : NWTS4 NWTS5 focal diffuse anaplasia tumor PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Wilms tumor childhood kidney tumor</keyword>
</DOC>